Identification of potential missed opportunities for human papillomavirus (HPV) vaccination in women referred to an academic colposcopy clinic for evaluation of abnormal cervical cytology

References

• American Cancer Society. Cancer Facts & Figures. Atlanta, Ga: American Cancer Society 2015.
   Google Scholar
• Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsaque X, Shah KV, Snijders PJF, Meijer CJLM. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348:518–27; PMID:12571259; http://dx.doi.org/10.1056/NEJMoa021641
   PubMed Web of Science ®Google Scholar
• Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009; 374:301–14; PMID:19586656; http://dx.doi.org/10.1016/S0140-6736(09)61248-4
   PubMed Web of Science ®Google Scholar
• Future II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356:1915–27; PMID:17494925; http://dx.doi.org/10.1056/NEJMoa061741
   PubMed Web of Science ®Google Scholar
• Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GWK, Ferris DG, Steben M, Bryan J, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007; 356:1928–43; PMID:17494926; http://dx.doi.org/10.1056/NEJMoa061760
   PubMed Web of Science ®Google Scholar
• Saslow D, Castle PE, Cox JT, Davey DD, Einstein MH, Ferris DG, Goldie SJ, Harper DM, Kinney W, Moscicki AB, et al. American cancer society guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin 2007; 57:7–28; PMID:17237032; http://dx.doi.org/10.3322/canjclin.57.1.7
   PubMed Web of Science ®Google Scholar
• Committee opinion no. 588: human papillomavirus vaccination. Obstet Gynecol 2014; 123:712–8; PMID:24553168; http://dx.doi.org/10.1097/01.AOG.0000444458.00612.6b
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2007; 56:1–24; PMID:17380109
   PubMedGoogle Scholar
• National and state vaccination coverage among adolescents aged 13 through 17 years–United States. MMWR Morb Mortal Wkly Rep 2011 2010; 60:1117–23.
   Google Scholar
• Kessels SJ, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine 2012; 30:3546–56; PMID:22480928; http://dx.doi.org/10.1016/j.vaccine.2012.03.063
   PubMed Web of Science ®Google Scholar
• Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J, Curtis R, Markowitz L. Human Papillomavirus Vaccination Coverage Among Adolescents, 2007–2013, and Postlicensure Vaccine Safety Monitoring, 2006–2014 — United States. MMWR Morb Mortal Wkly Rep 2014; 63:620–4; PMID:25055185
   PubMed Web of Science ®Google Scholar
• Williams WW, Lu PJ, O'Halloran A, Bridges CB, Kim DK, Pilishvili T, Hales CM, Markowitz LE. Vaccination coverage among adults, excluding influenza vaccination - United States, 2013. MMWR Morb Mortal Wkly Rep 2015; 64:95–102; PMID:25654611
   PubMed Web of Science ®Google Scholar
• National Vaccine Advisory Committee. Accelerating HPV vaccine uptake: urgency for action to prevent cancer. A report to the President of the United States from the President's cancer panel. Bethesda, MD: National Cancer Institute; 2014.
   Google Scholar
• Leddy MA, Anderson BL, Gall S, Schulkin J. Obstetrician-gynecologists and the HPV vaccine: practice patterns, beliefs, and knowledge. J Pediatr Adolesc Gynecol 2009; 22:239–46; PMID:19646670; http://dx.doi.org/10.1016/j.jpag.2008.09.002
   PubMed Web of Science ®Google Scholar
• Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD. Predictors of HPV vaccine uptake among women aged 19–26: importance of a physician's recommendation. Vaccine 2011; 29:90–5; PMID:20056186; http://dx.doi.org/10.1016/j.vaccine.2009.12.063
   PubMed Web of Science ®Google Scholar
• Curtis CR, Dorell C, Yankey D, Jeyarajah J, Chesson H, Saraiya M, Gold R, Dunne EF, Stokley S. National Human Papillomavirus Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey – Teen, United States, 2011. MMWR 2014; 63:61–70; PMID:25208260
   PubMed Web of Science ®Google Scholar
• Laz TH, Rahman M, Berenson. Human papillomavirus vaccine uptake among 18–26 year old women in the United States: The National Health Interview Survey, 2010. Cancer 2013; 119:1386–92; PMID:23508594; http://dx.doi.org/10.1002/cncr.27894
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56:1–24; PMID:17380109
   PubMedGoogle Scholar
• Tedaldi EM, Baker RK, Moorman AC, Wood KC, Fuhrer J, McCabe RE, Holmberg SD. Hepatitis A and B vaccination practices for ambulatory patients infected with HIV. Clin Infect Dis 2004; 38:1478–84; PMID:15156488; http://dx.doi.org/10.1086/420740
   PubMed Web of Science ®Google Scholar
• Etter DJ, Zimet GD, Rickert VI. Human papillomavirus vaccine in adolescent women: a 2012 update. Curr Opin Obstet Gynecol 2012; 24:305–10; PMID:22781077; http://dx.doi.org/10.1097/GCO.0b013e3283567005
   PubMed Web of Science ®Google Scholar
• Clifford G, Franceschi S, Diaz M, Munoz N, Villa LL. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 2006; 24(S3):26–34; http://dx.doi.org/10.1016/j.vaccine.2006.05.026
   Web of Science ®Google Scholar
• Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, Moreira ED, Ngan Y, Petersen LK, Lazcano-Ponce E, et al. A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women. N Engl J Med 2015; 372:711–23; PMID:25693011; http://dx.doi.org/10.1056/NEJMoa1405044
   PubMed Web of Science ®Google Scholar
• Charlton BM, Carwile JL, Michels KB, Feldman S. A cervical abnormality risk prediction model: can we use clinical information to predict which patients with ASCUS/LSIL pap tests will develop CIN 2/3 or AIS? J Low Genit Tract Dis 2013; 17:242–7; PMID:23486071; http://dx.doi.org/10.1097/LGT.0b013e3182730fec
   PubMed Web of Science ®Google Scholar
• Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, Solomon D, Wentzensen N, Lawson HW. updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors, 2012. Obstet Gynecol 2013; 121:829–46; PMID:23635684; http://dx.doi.org/10.1097/AOG.0b013e3182883a34
   PubMed Web of Science ®Google Scholar
• Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. Consensus guidelines for the management of women with abnormal cervical cancer screening tests, 2006. Am J Obstet Gynecol 2007; 197:346–55; http://dx.doi.org/10.1016/j.ajog.2007.07.047
   PubMed Web of Science ®Google Scholar
• Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ, 2006. Am J Obstet Gynecol 2007; 197:340–5; http://dx.doi.org/10.1016/j.ajog.2007.07.050
   PubMed Web of Science ®Google Scholar
• Miettinen OS. Theoretical epidemiology : principles of occurrence research in medicine. A Wiley medical publication. New York: Wiley. 1985; xxii: 1–359.
   Google Scholar